BACKGROUND
Primary breast angiosarcoma (PBA) is rare, and limited data exist because studies often combine primary and secondary angiosarcoma patients.
METHODS
For patients with PBA who received care at a comprehensive cancer center from 1991 to 2025 and underwent surgical resection, this retrospective study collecte...
Rick D. Vavolizza, A. Subramaniam, Min Yi et al.· Annals of Surgical Oncology· 0 citations
ABSTRACT Cellular therapies representa promising area of immunotherapy for advanced cancers,therapies including T cell receptor (TCR) therapies, chimeric antigen receptor (CAR) T cell therapies, tumor-infiltrating lymphocyte (TIL) therapies, and natural killer (NK) cell therapies.Sarcomas pose unique challenges due to...
C. Wannaphut, P. Thirasastr, J. Livingston et al.· Human Vaccines & Immunothera...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.